Global Sterile Injectable Outsourcing Report 2022 – Cold-chain Capabilities that Support Next-gen Biologics Present Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Growth Opportunities in Sterile Injectable Outsourcing” report has been added to ResearchAndMarkets.com’s offering. Injectables constitute one of the fastest-growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off-patent in the next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The … [Read more…]
